查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1446812

全球直飼微生物市場 - 2023-20230

Global Direct-Fed Microbials Market - 2023-20230
出版日期: | 出版商: DataM Intelligence | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2022年，全球直飼微生物市場達到12.132億美元，預計2030年將達到21.225億美元，2023-2030年預測期間CAGR為7.8%。

全球畜牧業生產擴張是直飼微生物市場成長的主要趨勢。對肉、蛋和奶等動物產品不斷成長的需求正在增加畜牧業產量。據聯合國糧農組織稱，到 2030 年，牛肉、豬肉、雞肉和羊肉的蛋白質含​​量將分別增加 5.9%、13.1%、17.8% 和 15.7%。為了滿足這種不斷成長的需求，人們更加重視最佳化動物飼料健康和營養推動了DFM 市場的成長。

抗生素抗藥性問題及其對畜牧業的影響促使抗生素使用量減少。因此，直接飼餵微生物 (DFM) 產品擴大被用作抗生素的替代品，以確保動物健康和最佳化性能。這些微生物解決方案提供了一種更永續、更有效的方法，符合更乾淨、更安全的畜牧生產的需求。因此，DFM 的使用量不斷增加，有助於減少動物養殖中的抗生素使用，並促進更健康、更有效率的畜牧系統。

由於對禽肉和禽蛋的需求不斷成長，家禽在直飼微生物市場中佔有重要佔有率。由於畜牧業的不斷發展，北美在直接飼餵微生物市場中佔有重要佔有率。根據美國飼料工業協會統計，美國每年有超過 5,800 家動物食品製造廠生產超過 2.84 億噸成品飼料和寵物食品。

動力學

動物疾病盛行率增加

各種動物疾病的不斷爆發正在推動直飼微生物市場的成長。據美國疾病管制與預防中心稱，在美國，與動物或其環境有關的腸道疾病預計每年導致 45 萬例疾病、5,000 例住院病例和 76 例死亡。 DFM可以透過促進腸道微生物群平衡來增強動物的免疫功能

DFM 可以幫助減輕動物的壓力，使它們不易感染疾病。降低壓力水平可以使動物更健康並減少疾病相關問題。動物疾病會對畜牧生產者造成重大經濟損失。透過使用 DFM 預防疾病，生產者可以減輕這些損失，從而提高獲利能力。

對動物性蛋白質的需求不斷增加

根據糧農組織預測，到 2030 年，全球動物性蛋白質平均消耗量將比 2018-2020 年基期平均值增加 14%。為了滿足對肉、奶和蛋等動物性蛋白質不斷成長的需求，畜牧生產者不斷尋求各種產品來提高動物的生產性能。 DFM 的使用有助於牲畜的整體健康。這進一步幫助畜牧生產者更有效地滿足對動物蛋白質不斷成長的需求。

DFM 可以提高牲畜的生產力，進而提高每頭動物的產量。在動物性蛋白質需求不斷成長的環境中，最大限度地提高生產力對於獲利能力至關重要。 DFM 透過最佳化飼料中營養物質的利用並促進動物更健康的生長來幫助實現這一目標。

嚴格監管

各種國際機構和監管機構，包括美國食品藥物管理局（FDA）、歐洲食品安全局（EFSA）、歐盟委員會（EC）、世界衛生組織（WHO）、美國獸醫中心（CVM）等。在調節直接飼餵微生物等飼料添加劑方面發揮著至關重要的作用。他們執行嚴格的法規，以確保動物益生菌的安全、品質和有效性。

滿足監管要求（包括產品測試和文件記錄）可能既昂貴又耗時。公司必須在研究、品質控制和合規工作上投入資源，以確保其 DFM 產品符合特定的標準和法規。這些成本可能成為小型企業的進入障礙，也可能成為老牌企業的負擔。

目錄

第 1 章：方法與範圍

  • 研究方法論
  • 報告的研究目的和範圍

第 2 章：定義與概述

第 3 章：執行摘要

  • 按類型分類的片段
  • 按表格列出的片段
  • 牲畜片段
  • 按地區分類的片段

第 4 章：動力學

  • 影響因素
    • 促進要素
      • 動物疾病盛行率增加
      • 對動物性蛋白質的需求不斷增加
    • 限制
      • 嚴格監管
    • 機會
    • 影響分析

第 5 章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆發前的情景
    • 新冠疫情期間的情景
    • 新冠疫情後的情景
  • COVID-19 期間的定價動態
  • 供需譜
  • 疫情期間政府與市場相關的舉措
  • 製造商策略舉措
  • 結論

第 7 章：按類型

  • 乳酸菌
    • 乳酸桿菌
    • 雙歧桿菌
    • 嗜熱鏈球菌
  • 芽孢桿菌
  • 酵母菌
  • 其他

第 8 章：按形式

  • 乾燥
  • 液體

第 9 章：依牲畜分類

  • 豬
  • 家禽
  • 反芻動物
  • 水生動物
  • 其他

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 俄羅斯
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • ADM Animal Nutrition
    • 公司簡介
    • 產品組合和描述
    • 財務概覽
    • 最近的發展
  • Chr. Hansen Holding A/S
  • Phibro Animal Health Corporation
  • Kemin Industries, Inc
  • Novozymes
  • Bio-Vet
  • Evonik Industries AG
  • Adisseo
  • The Fertrell Company
  • CALPIS AMERICA

第 13 章：附錄

簡介目錄
Product Code: AG7981

Overview

Global Direct-Fed Microbials Market reached US$ 1,213.2 million in 2022 and is expected to reach US$ 2,122.5 million by 2030, growing with a CAGR of 7.8% during the forecast period 2023-2030.

Global expansion of livestock production acts as a key trend for direct-fed microbials market growth. The growing demand for animal products like meat, eggs, and milk is increasing livestock production. According to FAO, beef, pork, chicken, and sheep meat will each have an increased protein content of 5.9%, 13.1%, 17.8%, and 15.7% by 2030. To meet this increasing demand, there is a greater focus on optimizing animal health and nutrition which drives the DFM market growth.

Antibiotic resistance concerns and their impact on animal agriculture have prompted a decrease in antibiotic usage. In response, direct-fed microbial (DFM) products are increasingly adopted as alternatives to antibiotics for safeguarding animal health and optimizing performance. These microbial solutions offer a more sustainable and effective approach, aligning with the need for cleaner and safer livestock production. As a result, DFM usage is on the rise, contributing to the reduction of antibiotics in animal farming and fostering healthier, more efficient livestock systems.

Poultry holds a significant share of the direct-fed microbial market due to the rising demand for poultry meat and poultry eggs. North America held a significant share of the direct-fed microbial market due to its growing livestock industry. According to the America Feed Industry Association, each year, more than 284 million tonnes of finished feed and pet food are produced in the United States by more than 5,800 animal food manufacturing plants.

Dynamics

Increasing Prevalence of Animal Diseases

The growing outbreak of various animal diseases is boosting the direct-fed microbial market growth. According to the Centers for Disease Control and Prevention, in the United States, enteric diseases connected to animals or their environment are anticipated to be responsible for 450,000 illnesses, 5,000 hospitalizations, and 76 fatalities annually. DFM can enhance the immune function of animals by promoting a balanced gut microbiome

DFM can help reduce stress in animals, which, in turn, makes them less vulnerable to diseases. Reduced stress levels can result in healthier animals and fewer disease-related issues. Animal diseases can result in significant economic losses for livestock producers. By using DFM to prevent diseases, producers can mitigate these losses, leading to improved profitability.

Increasing Demand for Animal Protein

According to FAO projections, the average global consumption of animal proteins will rise by 14% by 2030 compared to the base period average of 2018-2020. To meet this type of rising demand for animal protein, like meat, milk, and eggs, livestock producers are constantly seeking various products to enhance animal performance. The use of DFM contributes to the overall health of livestock. This, further, helps livestock producers meet the growing demand for animal protein more efficiently.

DFM can boost the productivity of livestock, leading to higher production yields per animal. In an environment where demand for animal protein is rising, maximizing productivity becomes crucial for profitability. DFM assists in achieving this goal by optimizing the utilization of nutrients in the feed and promoting healthier growth in animals.

Stringent Regulation

Various international bodies and regulatory authorities, including the US Food and Drug Administration (FDA), European Food Safety Authority (EFSA), European Commission (EC), World Health Organization (WHO), US Center of Veterinary Medicine (CVM), etc. play a vital role in regulating feed additives like direct-fed microbials. They enforce stringent regulations to ensure the safety, quality, and effectiveness of animal probiotics.

Meeting regulatory requirements, including product testing and documentation, can be expensive and time-consuming. Companies have to invest resources in research, quality control, and compliance efforts to ensure their DFM products adhere to specific standards and regulations. These costs can be a barrier to entry for smaller businesses and a burden on established ones.

Segment Analysis

The global direct-fed microbials market is segmented based on type, form, livestock and region.

Growing consumption of Poultry Meat

Poultry is one of the largest and fastest-growing segments of the global livestock. They are farmed for meat and eggs. According to FAO, for the period 2021-30, global consumption of poultry meat is expected to rise to 152 Mt, making up 52% of the increased meat consumed. This extensive poultry product consumption provides a substantial market for direct-fed microbial products to improve poultry's health and growth.

Direct-fed microbials have a substantial impact on the productivity of poultry. By enhancing digestion, nutrient absorption, and overall health, DFM can lead to faster weight gain, increased egg production, and improved feed efficiency in poultry. DFM helps in producing healthier poultry without the use of antibiotics, aligning with consumer expectations.

Geographical Penetration

North America's Growing Animal Protein Consumption

North America has a highly developed and technologically advanced livestock industry. According to the World Animal Foundation, in the U.S., the per capita consumption of broiler, beef, and pork in 2022 was 98.8 pounds, 58.8 pounds and 51.6 pounds respectively. This extensive meat consumption creates a significant market for direct-fed microbial products, as they are widely used to improve animal health, productivity, and sustainability.

Due to concerns about antibiotic resistance and the need for antibiotic alternatives, North America has been actively exploring DFM as a solution. This trend has driven the demand for DFM products in the region. North American consumers have been increasingly seeking natural and sustainable food products, including meat and dairy. The use of DFM in livestock production aligns with consumer preferences for antibiotic-free, environmentally friendly, and healthier animal products.

Competitive Landscape

The major global players include ADM Animal Nutrition, Chr. Hansen Holding A/S, Phibro Animal Health Corporation, Kemin Industries, Inc, Novozymes, Bio-Vet, Evonik Industries AG, Adisseo, The Fertrell Company, CALPIS AMERICA

COVID-19 Impact Analysis

COVID Impact

The pandemic initially disrupted global supply chains, affecting the production and distribution of various agricultural and livestock products, including DFM. This led to shortages and increased costs for DFM manufacturers and farmers. At the outset of the pandemic, there was a decrease in demand for meat products due to supply chain disruptions and changing consumer behavior. This might have affected the DFM market, as these products are often used in animal feed to enhance livestock growth and health.

The DFM market is significant in animal agriculture, particularly in livestock farming. COVID-19 outbreaks in meat processing facilities and disruptions in the food supply chain impacted the livestock industry. However, some farmers might have turned to DFM products to improve animal health and productivity.

Russia- Ukraine War Impact

The conflict disrupted transportation routes and supply chains in the region, it affected the availability of DFM products in affected areas. Manufacturers and distributors faced challenges in moving their products. Geopolitical tensions and conflicts can lead to economic and political instability in affected regions. This instability influenced market dynamics, including demand for DFM products.

Currency devaluations and fluctuations in exchange rates impacted the cost of imported and exported goods, which might affect international trade in DFM products. In times of geopolitical conflict, regulatory changes or restrictions imposed on imports and exports, potentially affect the international trade of DFM products.

By Type

  • Lactic Acid Bacteria
    • Lactobacilli
    • Bifidobacteria
    • Streptococcus thermophilus
  • Bacillus Bacteria
  • Yeast
  • Others

By Form

  • Dry
  • Liquid

By Livestock

  • Swine
  • Poultry
  • Ruminants
  • Aquatic Animals
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In January 2023, Danisco Animal Nutrition & Health, a business unit of IFF, announced that it had received approval from the Canadian Food Inspection Agency (CFIA) for Enviva PRO and Syncra SWI. A multi-strain viable microbial product (VMP) called Enviva PRO is being utilized in more than 50 countries and is backed by a wealth of academic research.
  • In August 2023, scientists from the University of Minnesota College of Veterinary Medicine and the College of Food, Agricultural, and Natural Resource Sciences discovered that chickens given host-specific probiotic strains were healthier and more productive than chickens given non-host-specific strains.
  • On June 09, 2020, With the proprietors of UAS Laboratories LLC ("UAS Labs"), Chr. Hansen Holding A/S has today signed an agreement to acquire 100% of the Wisconsin-based B2B firm that specializes in clinically proven probiotics.

Why Purchase the Report?

  • To visualize the global direct-fed microbials market segmentation based on type, form, livestock and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of direct-fed microbials market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global direct-fed microbials market report would provide approximately 61 tables, 59 figures and 189 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Livestock
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Animal Diseases
      • 4.1.1.2. Increasing Demand for Animal Protein
    • 4.1.2. Restraints
      • 4.1.2.1. Stringent Regulation
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Lactic Acid Bacteria *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Lactobacilli
    • 7.2.4. Bifidobacteria
    • 7.2.5. Streptococcus thermophilus
  • 7.3. Bacillus Bacteria
  • 7.4. Yeast
  • 7.5. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Dry*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid

9. By Livestock

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Livestock
    • 9.1.2. Market Attractiveness Index, By Livestock
  • 9.2. Swine*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Poultry
  • 9.4. Ruminants
  • 9.5. Aquatic Animals
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Livestock
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Livestock
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. UK
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Russia
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Livestock
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Livestock
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Livestock

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. ADM Animal Nutrition*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Recent Developments
  • 12.2. Chr. Hansen Holding A/S
  • 12.3. Phibro Animal Health Corporation
  • 12.4. Kemin Industries, Inc
  • 12.5. Novozymes
  • 12.6. Bio-Vet
  • 12.7. Evonik Industries AG
  • 12.8. Adisseo
  • 12.9. The Fertrell Company
  • 12.10. CALPIS AMERICA

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us